A growing reliance on industry-sponsored cancer clinical trials in the United States is a reason for concern, say researchers from the UNC Lineberger Comprehensive Cancer Center.

Eva Madrid, the Lead of Cochrane’s new Iberoamérica Evidence Synthesis Unit, spoke on the panel of the launch event for the ...

Over the past decade, decreasing vaccination rates now threaten the huge beneficial impacts of vaccinations in the U.S. and globally. Researchers discuss the multifactorial barriers including ...

Dr. Barry Davies joins Mosaic Therapeutics as CSO, bringing 25 years of drug discovery expertise to advance targeted oncology therapies and precision medicine.

Significant investments in digital health, telemedicine, and Artificial Intelligence (AI)-driven diagnostics have reshaped ...

The current expectation is that every ovulatory menstrual cycle will have a luteal phase (the time from egg released until ...

The current expectation is that every ovulatory menstrual cycle will have a luteal phase (the time from egg released until ...

In new research, a team led by University of Cincinnati researchers has identified a potential new way to make radiation more ...

Abivax Announces First Patient Enrolled in ENHANCE-CD, the Phase 2b Trial of Obefazimod in Crohn’s Disease ...